Period of time： 2003年1期
Publisher： Taylor & Francis Ltd
Founded in： 1986
Total resources： 3
ISSN： 1055-9612
Subject： R9 Pharmacy
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Drug Design and Discovery,volume 18,issue 1
Menu
Access to resources
Recommend
By Sarabu Ramakanth,Bolin David R.,Campbell Robert,Cooper Joel P.,Cox Donald,Gaizband Diana,Makofske Raymond,Nagy Zoltan,Olson Gary L. in (2002)
Drug Design and Discovery,volume 18,issue 1 , Vol. 18, Iss. 1, 2002-03 , pp.By Lattmann Eric,Billington David C.,Poyner David R.,Arayarat Pornthip,Howitt Stephen B.,Lawrence Spencer,Offel Michael in (2002)
Drug Design and Discovery,volume 18,issue 1 , Vol. 18, Iss. 1, 2002-03 , pp.QSAR of Human Factor Xa Inhibitor N2-Aroylanthranilamides Using Principal Component Factor Analysis
By Roy Kunal,De A. U.,Sengupta Chandana in (2002)
Drug Design and Discovery,volume 18,issue 1 , Vol. 18, Iss. 1, 2002-03 , pp.QSAR With Electrotopological State Atom Index: Human Factor Xa Inhibitor N2-Aroylanthranilamides
By Roy Kunal,De A. U.,Sengupta Chandana in (2002)
Drug Design and Discovery,volume 18,issue 1 , Vol. 18, Iss. 1, 2002-03 , pp.